Literature DB >> 12364369

Atopic dermatitis and fungi.

Jan Faergemann1.   

Abstract

Atopic dermatitis (AD) is a chronic, itching, inflammatory skin disease which is associated with asthma and/or hay fever and a familial occurrence of these conditions. Genetic factors are important in the development of AD, but the exact hereditary pathway is still unknown. Dry skin and the weakened barrier function in patients with AD is very important for the patient's reactions to irritants and other external trigger factors including microorganisms. The standard treatments are topical corticosteroids, topical immunomodulating agents, and emollients. If AD cannot be controlled by this type of treatment, systemic immunomodulating agents may be used. UVB, UVA, or psoralen-UVA may also be used for widespread severe lesions. However, some patients do not respond to these standard treatment, and then it is important to consider the role of microorganisms, house dust mites or food. The role of the Malassezia yeasts in AD, especially AD located to the head and neck region, is now documented in several papers. There are also several papers indicating the role of Candida as an aggravating factor in AD. Patients with AD also develop chronic dermatophyte infections more easily, and patients with AD and chronic dermatophyte infections may show improvement in their AD when treated with antifungal drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364369      PMCID: PMC126862          DOI: 10.1128/CMR.15.4.545-563.2002

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  131 in total

1.  The high-affinity receptor for IgE is the predominant IgE-binding structure in lesional skin of atopic dermatitis patients.

Authors:  R Klubal; B Osterhoff; B Wang; J P Kinet; D Maurer; G Stingl
Journal:  J Invest Dermatol       Date:  1997-03       Impact factor: 8.551

2.  Variations of Pityrosporum orbiculare in middle-aged and elderly individuals.

Authors:  I M Bergbrant; J Faergemann
Journal:  Acta Derm Venereol       Date:  1988       Impact factor: 4.437

3.  Trichophyton allergy in a 24-year-old man with "intrinsic" asthma.

Authors:  T A Platts-Mills; G P Fiocco; S Pollart; M L Hayden; S Jackson; S R Wilkins
Journal:  Ann Allergy       Date:  1986-06

4.  IgE-binding components in Pityrosporum orbiculare identified by an immunoblotting technique.

Authors:  S Johansson; K Karlström
Journal:  Acta Derm Venereol       Date:  1991       Impact factor: 4.437

5.  An assessment of the role of Candida albicans antigen in atopic dermatitis.

Authors:  E Morita; M Hide; Y Yoneya; M Kannbe; A Tanaka; S Yamamoto
Journal:  J Dermatol       Date:  1999-05       Impact factor: 4.005

6.  In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine.

Authors:  A K Gupta; Y Kohli; A Li; J Faergemann; R C Summerbell
Journal:  Br J Dermatol       Date:  2000-04       Impact factor: 9.302

7.  IFN-gamma plays a dominant role in upregulation of Candida-specific IgE synthesis in patients with atopic dermatitis.

Authors:  M Kimura; S Tsuruta; T Yoshida
Journal:  Int Arch Allergy Immunol       Date:  2000-07       Impact factor: 2.749

8.  Selective cloning of allergens from the skin colonizing yeast Malassezia furfur by phage surface display technology.

Authors:  M Lindborg; C G Magnusson; A Zargari; M Schmidt; A Scheynius; R Crameri; P Whitley
Journal:  J Invest Dermatol       Date:  1999-08       Impact factor: 8.551

9.  Allergen cross-reactivity between Pityrosporum orbiculare and Candida albicans.

Authors:  X Huang; S G Johansson; A Zargari; S L Nordvall
Journal:  Allergy       Date:  1995-08       Impact factor: 13.146

10.  IgE-sensitization to cellular and culture filtrates of fungal extracts in patients with atopic dermatitis.

Authors:  D Nissen; L J Petersen; R Esch; E Svejgaard; P S Skov; L K Poulsen; H Nolte
Journal:  Ann Allergy Asthma Immunol       Date:  1998-09       Impact factor: 6.347

View more
  28 in total

Review 1.  [Malassezia yeasts and their significance in dermatology].

Authors:  W Hort; M Nilles; P Mayser
Journal:  Hautarzt       Date:  2006-07       Impact factor: 0.751

2.  A new calcineurin inhibitor, pimecrolimus, inhibits the growth of Malassezia spp.

Authors:  Takashi Sugita; Mami Tajima; Hisae Tsubuku; Ryoji Tsuboi; Akemi Nishikawa
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

3.  In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains.

Authors:  Christine Roques; Sabine Brousse; Cédric Panizzutti
Journal:  Mycopathologia       Date:  2006-12       Impact factor: 2.574

Review 4.  [Influence of nutrition, common autoimmune diseases and smoking on the incidence of foot mycoses].

Authors:  G Daeschlein; L Rauch; H Haase; A Arnold; S Lutze; S von Podewils; M Niggemeier; M Jünger
Journal:  Hautarzt       Date:  2019-08       Impact factor: 0.751

Review 5.  Current insights into the role of human β-defensins in atopic dermatitis.

Authors:  P Chieosilapatham; H Ogawa; F Niyonsaba
Journal:  Clin Exp Immunol       Date:  2017-08-04       Impact factor: 4.330

6.  Molecular analysis of malassezia microflora on the skin of the patients with atopic dermatitis.

Authors:  Seon Mi Yim; Ji Young Kim; Jong Hyun Ko; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

7.  Gastrointestinal Candida colonisation promotes sensitisation against food antigens by affecting the mucosal barrier in mice.

Authors:  N Yamaguchi; R Sugita; A Miki; N Takemura; J Kawabata; J Watanabe; K Sonoyama
Journal:  Gut       Date:  2006-01-19       Impact factor: 23.059

8.  Sequence diversity of the intergenic spacer region of the rRNA gene of Malassezia globosa colonizing the skin of patients with atopic dermatitis and healthy individuals.

Authors:  Takashi Sugita; Minako Kodama; Masuyoshi Saito; Tomonobu Ito; Yukihiko Kato; Ryoji Tsuboi; Akemi Nishikawa
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Dandruff: the most commercially exploited skin disease.

Authors:  S Ranganathan; T Mukhopadhyay
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

10.  Revised culture-based system for identification of Malassezia species.

Authors:  Takamasa Kaneko; Koichi Makimura; Michiko Abe; Ryoko Shiota; Yuka Nakamura; Rui Kano; Atsuhiko Hasegawa; Takashi Sugita; Shuichi Shibuya; Shinichi Watanabe; Hideyo Yamaguchi; Shigeru Abe; Noboru Okamura
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.